Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 400

1.

Measurement invariance across gender and age groups, validity and reliability of the Chinese version of the short-form supportive care needs survey questionnaire (SCNS-SF34).

Choi EPH, Liao Q, Soong I, Chan KKL, Lee CCY, Ng A, Sze WK, Tsang JWH, Lee VHF, Lam WWT.

Health Qual Life Outcomes. 2020 Feb 17;18(1):29. doi: 10.1186/s12955-020-01289-0.

2.

Letter by Lee et al Regarding Article, "CTA-for-All: Impact of Emergency Computed Tomographic Angiography for All Patients With Stroke Presenting Within 24 Hours of Onset".

Lee VH, Heaton S, Powers CJ.

Stroke. 2020 Feb;51(2):e42. doi: 10.1161/STROKEAHA.119.028341. Epub 2020 Jan 9. No abstract available.

PMID:
31914882
3.

Radiation Therapy for Thoracic Malignancies.

Lee VH, Yang L, Jiang Y, Kong FS.

Hematol Oncol Clin North Am. 2020 Feb;34(1):109-125. doi: 10.1016/j.hoc.2019.09.007. Epub 2019 Oct 31. Review.

PMID:
31739938
4.

Asian Thoracic Oncology Research Group expert consensus statement on optimal management of stage III non-small cell lung cancer.

Tan WL, Chua KLM, Lin CC, Lee VHF, Tho LM, Chan AW, Ho GF, Reungwetwattana T, Yang JC, Kim DW, Soo RA, Chan Ahn Y, Onishi H, Ahn MJ, Mok TSK, Tan DSW, Yang F.

J Thorac Oncol. 2019 Nov 13. pii: S1556-0864(19)33640-8. doi: 10.1016/j.jtho.2019.10.022. [Epub ahead of print] Review.

PMID:
31733357
5.

Ginsenoside Rg1 activates ligand-independent estrogenic effects via rapid estrogen receptor signaling pathway.

Gao QG, Zhou LP, Lee VH, Chan HY, Man CW, Wong MS.

J Ginseng Res. 2019 Oct;43(4):527-538. doi: 10.1016/j.jgr.2018.03.004. Epub 2018 Mar 30.

6.

The Spectrum of Nontraumatic Convexity Subarachnoid Hemorrhage.

Forman R, Conners JJ, Song SY, John S, Garg R, Harris J, Lee VH.

J Stroke Cerebrovasc Dis. 2019 Dec;28(12):104473. doi: 10.1016/j.jstrokecerebrovasdis.2019.104473. Epub 2019 Oct 31.

PMID:
31677961
7.

Dose volume effects of re-irradiation for locally recurrent nasopharyngeal carcinoma.

Ng WT, Lee MC, Fung NT, Wong EC, Cheung AK, Chow JC, Au KH, Poon DM, Lai JW, Chiang CL, Choi HC, Chau TC, Lee VH, Lee AW.

Head Neck. 2020 Feb;42(2):180-187. doi: 10.1002/hed.25988. Epub 2019 Oct 16.

PMID:
31617636
8.

Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes.

Nicholls JM, Lee VH, Chan SK, Tsang KC, Choi CW, Kwong DL, Lam KO, Chan SY, Tong CC, So TH, Leung TW, Luk MY, Khong PL, Lee AW.

Br J Cancer. 2019 Oct;121(8):690-698. doi: 10.1038/s41416-019-0575-6. Epub 2019 Sep 17.

PMID:
31527689
9.

Non-invasive Potential Circulating mRNA Markers for Colorectal Adenoma Using Targeted Sequencing.

Xue VW, Cheung MT, Chan PT, Luk LLY, Lee VH, Au TC, Yu AC, Cho WCS, Tsang HFA, Chan AK, Wong SCC.

Sci Rep. 2019 Sep 10;9(1):12943. doi: 10.1038/s41598-019-49445-x.

10.

Differences Between the East and the West in Managing Advanced-Stage Non-small Cell Lung Cancer.

Lee VHF, Mok TSK, Goto Y, Hsue VCC, Yang L, Jiang Y, Leung DKC, Lau KS, Tse PY.

Clin Oncol (R Coll Radiol). 2020 Jan;32(1):e1-e9. doi: 10.1016/j.clon.2019.07.014. Epub 2019 Jul 30.

PMID:
31375307
11.

Patterns of care and treatment outcomes for local recurrence of NPC after definite IMRT-A study by the HKNPCSG.

Ng WT, Wong ECY, Cheung AKW, Chow JCH, Poon DMC, Lai JWY, Chiang CL, Choi HCW, Chau TC, Lee VHF, Lee AWM, Tam AHP, Au KH.

Head Neck. 2019 Oct;41(10):3661-3669. doi: 10.1002/hed.25892. Epub 2019 Jul 27.

PMID:
31350940
12.

Third-line systemic treatment in advanced/metastatic gastric cancer: a comprehensive review.

Chan WL, Lam KO, So TH, Lee VH, Kwong LD.

Ther Adv Med Oncol. 2019 Jun 29;11:1758835919859990. doi: 10.1177/1758835919859990. eCollection 2019. Review.

13.

Comparing dyadic cognitive behavioral therapy (CBT) with dyadic integrative body-mind-spirit intervention (I-BMS) for Chinese family caregivers of lung cancer patients: a randomized controlled trial.

Xiu D, Fung YL, Lau BH, Wong DFK, Chan CHY, Ho RTH, So TH, Lam TC, Lee VH, Lee AWM, Chow SF, Lim FM, Tsang MW, Chan CLW, Chow AYM.

Support Care Cancer. 2020 Mar;28(3):1523-1533. doi: 10.1007/s00520-019-04974-z. Epub 2019 Jul 6.

PMID:
31280363
14.

Contrasting Some Differences in Managing Advanced Unresectable Hepatocellular Carcinoma Between the East and the West.

Lee VHF, Seong J, Yoon SM, Wong TCL, Wang B, Zhang JL, Chiang CL, Ho PPY, Dawson LA.

Clin Oncol (R Coll Radiol). 2019 Aug;31(8):560-569. doi: 10.1016/j.clon.2019.06.002.

PMID:
31279433
15.

Advancing Care for Head and Neck Cancers in a Multidisciplinary Tumour Board in the East.

Lee VHF, Chan JYW, Vardhanabhuti V, Kwong DLW, Leung TW, Chan SY, Tong CC, Xu ZY, Shen L, Lee AWM.

Clin Oncol (R Coll Radiol). 2019 Aug;31(8):549-559. doi: 10.1016/j.clon.2019.05.023.

PMID:
31279432
16.

Integrative Palliative Cancer Care in Hong Kong: An Overview and an Example from the East.

Lee VHF, Lam TC, Jing HM, Liu F, Zhang YS, Huang JJ, Lee AWM.

Clin Oncol (R Coll Radiol). 2019 Aug;31(8):589-594. doi: 10.1016/j.clon.2019.06.001. Epub 2019 Jun 21.

PMID:
31230834
17.

East Meets West: Convergence of the Art and Science of Oncology.

Agarwal JP, Lee VH.

Clin Oncol (R Coll Radiol). 2019 Aug;31(8):487-489. doi: 10.1016/j.clon.2019.06.003. Epub 2019 Jun 20. No abstract available.

PMID:
31229380
18.

Oncology Healthcare Provision in Hong Kong: Viewpoint of a Clinical Oncologist.

Lee VH.

Clin Oncol (R Coll Radiol). 2019 Aug;31(8):490-491. doi: 10.1016/j.clon.2019.05.019. Epub 2019 Jun 8. No abstract available.

PMID:
31186165
19.

Chinese Medicine in Cancer Treatment - How is it Practised in the East and the West?

So TH, Chan SK, Lee VH, Chen BZ, Kong FM, Lao LX.

Clin Oncol (R Coll Radiol). 2019 Aug;31(8):578-588. doi: 10.1016/j.clon.2019.05.016. Epub 2019 Jun 6.

PMID:
31178347
20.

Gastric Cancer - From Aetiology to Management: Differences Between the East and the West.

Chan WL, Lam KO, Lee VHF, Davidson M, So TH, Li JS, Chau I, Kwong DLW.

Clin Oncol (R Coll Radiol). 2019 Aug;31(8):570-577. doi: 10.1016/j.clon.2019.05.012. Epub 2019 Jun 7.

PMID:
31178345
21.

Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis.

Wong TC, Chiang CL, Lee AS, Lee VH, Yeung CS, Ho CH, Cheung TT, Ng KK, Chok SH, Chan AC, Dai WC, Wong FC, Luk MY, Leung TW, Lo CM.

Surg Oncol. 2019 Mar;28:228-235. doi: 10.1016/j.suronc.2019.01.006. Epub 2019 Jan 29.

PMID:
30851906
22.

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy: who and how?

Lam KO, Tong CC, Lee VHF, Luk MY, Lam CW.

Lancet Oncol. 2019 Feb;20(2):e66. doi: 10.1016/S1470-2045(18)30867-2. No abstract available.

PMID:
30712799
23.

Loss of cell adhesion molecule L1 like promotes tumor growth and metastasis in esophageal squamous cell carcinoma.

Tang H, Jiang L, Zhu C, Liu R, Wu Y, Yan Q, Liu M, Jia Y, Chen J, Qin Y, Lee VH, Luo S, Wang Q, Guan XY.

Oncogene. 2019 Apr;38(17):3119-3133. doi: 10.1038/s41388-018-0648-7. Epub 2019 Jan 8.

PMID:
30622339
24.

Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma.

Lin W, Yip YL, Jia L, Deng W, Zheng H, Dai W, Ko JMY, Lo KW, Chung GTY, Yip KY, Lee SD, Kwan JS, Zhang J, Liu T, Chan JY, Kwong DL, Lee VH, Nicholls JM, Busson P, Liu X, Chiang AKS, Hui KF, Kwok H, Cheung ST, Cheung YC, Chan CK, Li B, Cheung AL, Hau PM, Zhou Y, Tsang CM, Middeldorp J, Chen H, Lung ML, Tsao SW.

Nat Commun. 2018 Nov 7;9(1):4663. doi: 10.1038/s41467-018-06889-5.

25.

Management of Nasopharyngeal Carcinoma: Is Adjuvant Therapy Needed?

Lee VH, Lam KO, Chang AT, Lam TC, Chiang CL, So TH, Choi CW, Lee AW.

J Oncol Pract. 2018 Oct;14(10):594-602. doi: 10.1200/JOP.18.00219. Review.

PMID:
30312564
26.

The addition of pretreatment plasma Epstein-Barr virus DNA into the eighth edition of nasopharyngeal cancer TNM stage classification.

Lee VH, Kwong DL, Leung TW, Choi CW, O'Sullivan B, Lam KO, Lai V, Khong PL, Chan SK, Ng CY, Tong CC, Ho PP, Chan WL, Wong LS, Leung DK, Chan SY, So TH, Luk MY, Lee AW.

Int J Cancer. 2019 Apr 1;144(7):1713-1722. doi: 10.1002/ijc.31856. Epub 2018 Dec 24.

PMID:
30192385
27.

A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening.

Tong CC, Lam CW, Lam KO, Lee VHF, Luk MY.

Front Oncol. 2018 Jul 24;8:279. doi: 10.3389/fonc.2018.00279. eCollection 2018.

28.
29.

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial.

Chan ATC, Hui EP, Ngan RKC, Tung SY, Cheng ACK, Ng WT, Lee VHF, Ma BBY, Cheng HC, Wong FCS, Loong HHF, Tong M, Poon DMC, Ahuja AT, King AD, Wang K, Mo F, Zee BCY, Chan KCA, Lo YMD.

J Clin Oncol. 2018 Jul 10:JCO2018777847. doi: 10.1200/JCO.2018.77.7847. [Epub ahead of print]

PMID:
29989858
30.

Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese.

Ko JM, Tsang KH, Dai W, Choi SSA, Leong MM, Ngan RK, Kwong DL, Cheng A, Lee AW, Ng WT, Tung S, Lee VH, Lam KO, Chan CK, Lung ML.

Int J Cancer. 2018 Nov 1;143(9):2289-2298. doi: 10.1002/ijc.31617. Epub 2018 Aug 7.

31.

Molecular subtyping of cancer: current status and moving toward clinical applications.

Zhao L, Lee VHF, Ng MK, Yan H, Bijlsma MF.

Brief Bioinform. 2019 Mar 25;20(2):572-584. doi: 10.1093/bib/bby026. Review.

PMID:
29659698
32.
33.

Case sharing of a patient re-challenged with afatinib for EGFR-mutated advanced non-small cell lung cancer.

Lee VHF.

Asia Pac J Clin Oncol. 2018 Mar;14 Suppl 1:4-6. doi: 10.1111/ajco.12854.

PMID:
29508939
34.

Prognostic significance of Cytokeratin 20-positive lymph node vascular endothelial growth factor A mRNA and chromodomain helicase DNA binding protein 4 in pN0 colorectal cancer patients.

Wong SCC, Cheung MT, Luk LLY, Lee VHM, Chan PT, Tsang HFA, Wong EYK, Xue VW, Chan AKC, Chan JKC.

Oncotarget. 2017 Dec 19;9(6):6737-6751. doi: 10.18632/oncotarget.23424. eCollection 2018 Jan 23.

35.

Study protocol of a randomized controlled trial comparing integrative body-mind-spirit intervention and cognitive behavioral therapy in fostering quality of life of patients with lung cancer and their family caregivers.

Lau BH, Chow AYM, Wong DFK, Chan JSM, Chan CHY, Ho RTH, So TH, Lam TC, Lee VH, Lee AWM, Chow SF, Chan CLW.

J Evid Inf Soc Work. 2018 May-Jun;15(3):258-276. doi: 10.1080/23761407.2018.1435325. Epub 2018 Feb 5.

PMID:
29400621
36.

Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study).

Au KH, Ngan RKC, Ng AWY, Poon DMC, Ng WT, Yuen KT, Lee VHF, Tung SY, Chan ATC, Sze HCK, Cheng ACK, Lee AWM, Kwong DLW, Tam AHP.

Oral Oncol. 2018 Feb;77:16-21. doi: 10.1016/j.oraloncology.2017.12.004. Epub 2017 Dec 12.

PMID:
29362121
37.

Minimal Physiologically Based Pharmacokinetic and Drug-Drug-Disease Interaction Model of Rivaroxaban and Verapamil in Healthy and Renally Impaired Subjects.

Ismail M, Lee VH, Chow CR, Rubino CM.

J Clin Pharmacol. 2018 Apr;58(4):541-548. doi: 10.1002/jcph.1044. Epub 2017 Dec 14.

PMID:
29239000
38.

Head and neck cancer in Hong Kong.

Ng WT, Wong ECY, Lee VHF, Chan JYW, Lee AWM.

Jpn J Clin Oncol. 2018 Jan 1;48(1):13-21. doi: 10.1093/jjco/hyx151. Review.

PMID:
29145620
39.

Intravoxel incoherent motion MR imaging in nasopharyngeal carcinoma: comparison and correlation with dynamic contrast enhanced MR imaging.

Lai V, Lee VHF, Lam KO, Huang B, Chan Q, Khong PL.

Oncotarget. 2017 Jul 26;8(40):68472-68482. doi: 10.18632/oncotarget.19575. eCollection 2017 Sep 15.

40.

Cervical nodal volume for prognostication and risk stratification of patients with nasopharyngeal carcinoma, and implications on the TNM-staging system.

Yuan H, Ai QY, Kwong DL, Fong DY, King AD, Vardhanabhuti V, Lee VH, Khong PL.

Sci Rep. 2017 Sep 4;7(1):10387. doi: 10.1038/s41598-017-10423-w.

41.

Oligopeptide Transport in Rat Lung Alveolar Epithelial Cells is Mediated by Pept2.

Gukasyan HJ, Uchiyama T, Kim KJ, Ehrhardt C, Wu SK, Borok Z, Crandall ED, Lee VHL.

Pharm Res. 2017 Dec;34(12):2488-2497. doi: 10.1007/s11095-017-2234-z. Epub 2017 Aug 22.

PMID:
28831683
42.

Deciphering mechanisms of acquired T790M mutation after EGFR inhibitors for NSCLC by computational simulations.

Zou B, Lee VHF, Chen L, Ma L, Wang DD, Yan H.

Sci Rep. 2017 Jul 26;7(1):6595. doi: 10.1038/s41598-017-06632-y.

43.

The Role of Radiotherapy in Epidermal Growth Factor Receptor Mutation-positive Patients with Oligoprogression: A Matched-cohort Analysis.

Chan OSH, Lee VHF, Mok TSK, Mo F, Chang ATY, Yeung RMW.

Clin Oncol (R Coll Radiol). 2017 Sep;29(9):568-575. doi: 10.1016/j.clon.2017.04.035. Epub 2017 May 9.

PMID:
28499791
44.

Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.

Lee VH, Kwong DL, Lam KO, Lai YC, Li Y, Tong CC, Ho PP, Chan WL, Wong LS, Leung DK, Chan SY, Chan FT, Leung TW, Lee AW.

Medicine (Baltimore). 2017 Apr;96(15):e6518. doi: 10.1097/MD.0000000000006518.

45.

Impact of intravenous contrast used in computed tomography on radiation dose to carotid arteries and thyroid in intensity-modulated radiation therapy planning for nasopharyngeal carcinoma.

Lee VHF, Ng SCY, Kwong DLW, Lam KO, Leung TW.

Med Dosim. 2017 Summer;42(2):137-144. doi: 10.1016/j.meddos.2017.02.005. Epub 2017 Apr 6.

PMID:
28392229
46.

Factors Associated with Fever in Intracerebral Hemorrhage.

Gillow SJ, Ouyang B, Lee VH, John S.

J Stroke Cerebrovasc Dis. 2017 Jun;26(6):1204-1208. doi: 10.1016/j.jstrokecerebrovasdis.2017.01.007. Epub 2017 Feb 7.

PMID:
28187992
47.

Neurocardiology.

Osteraas ND, Lee VH.

Handb Clin Neurol. 2017;140:49-65. doi: 10.1016/B978-0-444-63600-3.00004-0. Review.

PMID:
28187814
48.

Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma.

Lee VH, Kwong DL, Leung TW, Choi CW, Lai V, Ng L, Lam KO, Ng SC, Sze CK, Tong CC, Ho PP, Chan WL, Wong LS, Leung DK, Chan SY, Khong PL.

Oncotarget. 2017 Jan 17;8(3):5292-5308. doi: 10.18632/oncotarget.14137.

49.

Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations.

Seow WJ, Matsuo K, Hsiung CA, Shiraishi K, Song M, Kim HN, Wong MP, Hong YC, Hosgood HD 3rd, Wang Z, Chang IS, Wang JC, Chatterjee N, Tucker M, Wei H, Mitsudomi T, Zheng W, Kim JH, Zhou B, Caporaso NE, Albanes D, Shin MH, Chung LP, An SJ, Wang P, Zheng H, Yatabe Y, Zhang XC, Kim YT, Shu XO, Kim YC, Bassig BA, Chang J, Ho JC, Ji BT, Kubo M, Daigo Y, Ito H, Momozawa Y, Ashikawa K, Kamatani Y, Honda T, Sakamoto H, Kunitoh H, Tsuta K, Watanabe SI, Nokihara H, Miyagi Y, Nakayama H, Matsumoto S, Tsuboi M, Goto K, Yin Z, Shi J, Takahashi A, Goto A, Minamiya Y, Shimizu K, Tanaka K, Wu T, Wei F, Wong JY, Matsuda F, Su J, Kim YH, Oh IJ, Song F, Lee VH, Su WC, Chen YM, Chang GC, Chen KY, Huang MS, Yang PC, Lin HC, Xiang YB, Seow A, Park JY, Kweon SS, Chen CJ, Li H, Gao YT, Wu C, Qian B, Lu D, Liu J, Jeon HS, Hsiao CF, Sung JS, Tsai YH, Jung YJ, Guo H, Hu Z, Wang WC, Chung CC, Lawrence C, Burdett L, Yeager M, Jacobs KB, Hutchinson A, Berndt SI, He X, Wu W, Wang J, Li Y, Choi JE, Park KH, Sung SW, Liu L, Kang CH, Hu L, Chen CH, Yang TY, Xu J, Guan P, Tan W, Wang CL, Sihoe AD, Chen Y, Choi YY, Hung JY, Kim JS, Yoon HI, Cai Q, Lin CC, Park IK, Xu P, Dong J, Kim C, He Q, Perng RP, Chen CY, Vermeulen R, Wu J, Lim WY, Chen KC, Chan JK, Chu M, Li YJ, Li J, Chen H, Yu CJ, Jin L, Lo YL, Chen YH, Fraumeni JF Jr, Liu J, Yamaji T, Yang Y, Hicks B, Wyatt K, Li SA, Dai J, Ma H, Jin G, Song B, Wang Z, Cheng S, Li X, Ren Y, Cui P, Iwasaki M, Shimazu T, Tsugane S, Zhu J, Jiang G, Fei K, Wu G, Chien LH, Chen HL, Su YC, Tsai FY, Chen YS, Yu J, Stevens VL, Laird-Offringa IA, Marconett CN, Lin D, Chen K, Wu YL, Landi MT, Shen H, Rothman N, Kohno T, Chanock SJ, Lan Q.

Hum Mol Genet. 2017 Jan 15;26(2):454-465. doi: 10.1093/hmg/ddw414.

50.

Professor A.T. Florence: A towering figure in Pharmaceutics.

Lee VHL.

Int J Pharm. 2016 Nov 30;514(1):5-6. doi: 10.1016/j.ijpharm.2016.06.025. No abstract available.

PMID:
27863682

Supplemental Content

Support Center